About: Treatment of large stage I–II lung tumors using stereotactic body radiotherapy (SBRT): Planning considerations and early toxicity

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Treatment of large stage I–II lung tumors using stereotactic body radiotherapy (SBRT): Planning considerations and early toxicity Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article

Attributes	Values
rdf:type	Item
description	article (en) wetenschappelijk artikel (nl) наукова стаття, опублікована в грудні 2010 (uk) im Dezember 2010 veröffentlicher wissenschaftlicher Artikel (de)
publication date	wds:Q59587488-1678737D-E29B-4CA3-996E-B31778241E10
publication date	2010-12-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q59587488-2944897D-5985-4785-A4C4-509320F0AACB wds:Q59587488-61856763-8E61-4AF6-A90F-B93D946851A9 wds:Q59587488-66A80867-F60F-42F5-9CC5-C9BAA50363FD
author name string	Wilko F A R Verbakel David Palma Chin Loon Ong
rdfs:label	Treatment of large stage I–II lung tumors using stereotactic body radiotherapy (SBRT): Planning considerations and early toxicity (en) Treatment of large stage I–II lung tumors using stereotactic body radiotherapy (nl)
skos:prefLabel	Treatment of large stage I–II lung tumors using stereotactic body radiotherapy (SBRT): Planning considerations and early toxicity (en) Treatment of large stage I–II lung tumors using stereotactic body radiotherapy (nl)
name	Treatment of large stage I–II lung tumors using stereotactic body radiotherapy (SBRT): Planning considerations and early toxicity (en) Treatment of large stage I–II lung tumors using stereotactic body radiotherapy (nl)
author	wds:Q59587488-09971B70-0C00-4D1F-AEE5-AF202202CF1B wds:Q59587488-D059F862-3506-433E-8023-42998F1CEC7E
author	Suresh Senan Berend J Slotman
title	wds:Q59587488-925D9E51-8E36-4160-9CAC-B528DA00439C
title	Treatment of large stage I-II lung tumors using stereotactic body radiotherapy (SBRT): planning considerations and early toxicity (en)
page(s)	wds:Q59587488-3E2A9D2B-811D-40D1-896C-20F350FC0C07
page(s)	431-436
instance of	wds:Q59587488-EF02527C-D496-49C8-AC09-B9655D8F43AC
instance of	scholarly article
main subject	wds:Q59587488-8EF34FEB-84FD-453E-8E28-B356F046AAF3
main subject	hematology
PubMed ID	wds:Q59587488-260B3CDF-7637-4644-8862-C15EC15C2F21
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20971523
PubMed ID	20971523
published in	wds:Q59587488-40DF8EE6-D268-43D4-904F-6BB72C6FC05A
published in	Radiotherapy and Oncology
issue	wds:Q59587488-5A0019F5-DB75-4C69-A7E1-41A09D2502FC
volume	wds:Q59587488-B2B048EF-9D7C-4B54-A1F0-AE78DB3E44D2
issue	3
volume	97
DOI	wds:Q59587488-2B5FD4B5-B6FE-425C-A380-60075F6D5CA2
DOI	http://dx.doi.org/10.1016/J.RADONC.2010.10.003
DOI	10.1016/J.RADONC.2010.10.003
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q59587488
is cites work of	A review of stereotactic body radiotherapy - is volumetric modulated arc therapy the answer? Radiotherapy for a second primary lung cancer arising post-pneumonectomy: planning considerations and clinical outcomes. Comparison of clinical, tumour-related and dosimetric factors in grade 0-1, grade 2 and grade 3 radiation pneumonitis after stereotactic body radiotherapy for lung tumours Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non-small-cell lung cancer: a propensity-matched analysis. The role of stereotactic ablative radiotherapy for early-stage and oligometastatic non-small cell lung cancer: evidence for changing paradigms Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments. Radiation pneumonitis after stereotactic radiation therapy for lung cancer Predictive factors of symptomatic radiation pneumonitis in primary and metastatic lung tumors treated with stereotactic ablative body radiotherapy Is stereotactic ablative radiotherapy an alternative to surgery in operable stage I non-small cell lung cancer? Safety of high-dose-rate stereotactic body radiotherapy Volumetric modulated arc therapy with flattening filter free beams for isolated abdominal/pelvic lymph nodes: report of dosimetric and early clinical results in oligometastatic patients. Complications from Stereotactic Body Radiotherapy for Lung Cancer Complication probability for radiation pneumonitis (RP) after stereotactic body radiotherapy (SBRT). Stereotactic radiotherapy for early lung cancer: Evidence-based approach and future directions Outcome and toxicity of stereotactic body radiotherapy with helical tomotherapy for inoperable lung tumor: analysis of Grade 5 radiation pneumonitis Stereotactic body radiation therapy for a new lung cancer arising after pneumonectomy: dosimetric evaluation and pulmonary toxicity Induction of MiR-21 by Stereotactic Body Radiotherapy Contributes to the Pulmonary Fibrotic Response. Evaluating risk factors of radiation pneumonitis after stereotactic body radiation therapy in lung tumor: Meta-analysis of 9 observational studies Stereotactic body radiation therapy for post-pulmonary lobectomy isolated lung metastasis of thoracic tumor: survival and side effects Safety and efficacy of intensity-modulated stereotactic body radiotherapy using helical tomotherapy for lung cancer and lung metastasis Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial SBRT in operable early stage lung cancer patients. Impact of Tumor Size on Local Control and Pneumonitis After Stereotactic Body Radiation Therapy for Lung Tumors DART-bid: dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily: high local control in early stage (I/II) non-small-cell lung cancer. Examining tumor control and toxicity after stereotactic body radiotherapy in locally recurrent previously irradiated head and neck cancers: implications of treatment duration and tumor volume Impacts of lung and tumor volumes on lung dosimetry for nonsmall cell lung cancer Dosimetric analysis of rib interference of the CTV during interstitial brachytherapy of lung tumors. Predictors of pneumonitis-free survival following lung stereotactic body radiation therapy Moving targets in 4D-CTs versus MIP and AIP: comparison of patients data to phantom data. Response to: RILI model and the Covid-19 pneumonia: the radiation oncologist point of view Correlation of normal lung density changes with dose after stereotactic body radiotherapy (SBRT) for early stage lung cancer A treatment-planning comparison of three beam arrangement strategies for stereotactic body radiation therapy for centrally located lung tumors using volumetric-modulated arc therapy [Radiation pneumonitis after stereotactic body radiation therapy for early stage non-small cell lung cancer]. Risk factors for radiation pneumonitis after stereotactic radiation therapy for lung tumours: clinical usefulness of the planning target volume to total lung volume ratio.
is cites work of	wds:Q26801050-5D7F59B2-71FA-4BC9-9BC7-641D46A7A057 wds:Q36343856-ED1400D9-6C97-490A-AC88-FF240D898938 wds:Q41067520-0497E1F0-4CA2-4C99-AE71-F01D4797EBB1 wds:Q47105967-722A150F-76E4-4F88-A043-ED7BB90559C2 wds:Q34304095-A6BA6905-9EAE-49F0-B25A-1C132AD572EF wds:Q33786992-A5053A4E-4287-4068-9575-0A1AF427BB49 wds:Q35667829-944E4D1A-0B6E-4A53-BEE0-6B42896B3CCE wds:Q35036789-C1E98C32-A6EC-4A92-ACB4-D348A42CCFD8 wds:Q35113011-DC0DD8BA-66EC-4342-A3B2-4070E0DF9A55 wds:Q33582666-A8AC8F32-DC85-4E9D-A1E3-2B1497835880 wds:Q38705654-6DA83A57-7DA4-4CBC-BD95-AE547EDF2EB5 wds:Q38233871-7C3B12EA-8FAC-4A82-96B6-8190AB96FB3B wds:Q50022920-D3D35721-2D01-4B38-891F-F0AFFA5CC05F wds:Q36550532-A1EF9055-666E-447B-98DB-D54A8620B377 wds:Q36980782-6A8BEDBD-7617-478C-9AE0-ADAC791ADBCC wds:Q61804645-FA39567C-C730-48A7-98EE-0EFE744A3FA7 wds:Q64982401-D7D92B8F-C022-4104-AC40-74DDA0F205CF wds:Q94590190-5C3EA994-E125-45C7-AC40-5436AE1C2124 wds:Q90095163-069766C5-E2DD-4CD2-8767-BAE31E78DFFD wds:Q29248448-31B38F2C-26FD-4F6B-9CD8-8973C9A992AD wds:Q36015400-73BBFD33-094D-47C2-9051-3816DE628E7F

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software